The results of a new study show the rate of colon cancer death in the United States for people with low socioeconomic status increased between 1980 and 2008 while it decreased during the same period ...

Colon cancer, the disease that took Chadwick Boseman's life, is the second deadliest cancer in the U.S. People of color are at a higher risk and cases for those 55 and under are on the rise. Risk ...

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss. Recent studies have found that GLP-1 medications ...

Colorectal cancer, also known as colon cancer, is one of the most common types of cancer in both men and women around the world. Once thought to be mainly a disease of older adults, it is now ...

Colon cancer patients taking GLP-1 drugs, like Ozempic, had better odds of survival in a new study. Weight loss and diabetes injections have well-known anti-inflammatory benefits. It could be that ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

Patients who survive colorectal cancer face a sustained and increased risk of death from chronic liver disease and cirrhosis ...